Literature DB >> 9884097

Mechanisms of progression of renal damage in lupus nephritis: pathogenesis of renal scarring.

J P Grande1.   

Abstract

Lupus nephritis results from an acute inflammatory and immunological response to renal immune complex deposition. The acute response is characterized by activation of circulating leukocytes and renal parenchymal cells, triggering the production of pro-inflammatory cytokines and growth factors. In all too many cases, this response is followed by a chronic response, which is characterized by excessive deposition of collagen and other extracellular matrix macromolecules and the development of end-stage renal disease. Mechanisms underlying this chronic response in progressive renal disease are not adequately defined. In this overview, potential roles of reactive oxygen species (ROS) generation and transforming growth factor-beta (TGF-beta) production in the pathogenesis of lupus nephritis are considered. ROS and TGF-beta may be key elements of a pathway leading to persistent and excessive matrix deposition in progressive lupus nephritis. Further studies to define the role of this pathway in lupus nephritis may lead to the development of additional, more specific therapeutic targets to prevent progression of renal disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9884097     DOI: 10.1191/096120398678920721

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  14 in total

1.  Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo.

Authors:  Nicole L Regna; Cristen B Chafin; Sarah E Hammond; Abdul G Puthiyaveetil; David L Caudell; Christopher M Reilly
Journal:  Clin Immunol       Date:  2014-01-15       Impact factor: 3.969

2.  Urinary N-acetyl-beta-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis.

Authors:  Dilek Erdener; Kenan Aksu; Ilhan Biçer; Eker Doğanavşargil; Fatma Z Kutay
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

3.  The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.

Authors:  Seth G Thacker; Celine C Berthier; Deborah Mattinzoli; Maria Pia Rastaldi; Matthias Kretzler; Mariana J Kaplan
Journal:  J Immunol       Date:  2010-08-30       Impact factor: 5.422

4.  Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage.

Authors:  Vijay Saxena; Douglas W Lienesch; Min Zhou; Ramireddy Bommireddy; Mohamad Azhar; Thomas Doetschman; Ram Raj Singh
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

5.  Poly(ADP-ribose) polymerase-1 regulates the progression of autoimmune nephritis in males by inducing necrotic cell death and modulating inflammation.

Authors:  Neelakshi R Jog; Joudy-Ann Dinnall; Stefania Gallucci; Michael P Madaio; Roberto Caricchio
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

6.  Isoflurane attenuates murine lupus nephritis by inhibiting NLRP3 inflammasome activation.

Authors:  Yi Yuan; Zhangsuo Liu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

7.  An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis.

Authors:  Deijanira Alves De Albuquerque; Vijay Saxena; David E Adams; Gregory P Boivin; Hermine I Brunner; David P Witte; Ram Raj Singh
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

8.  MicroRNA-let-7a promotes E2F-mediated cell proliferation and NFκB activation in vitro.

Authors:  Cristen B Chafin; Nicole L Regna; David L Caudell; Christopher M Reilly
Journal:  Cell Mol Immunol       Date:  2013-11-18       Impact factor: 11.530

9.  Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus.

Authors:  S Torabinejad; R Mardani; Z Habibagahi; J Roozbeh; P Khajedehi; M Pakfetrat; M A Banihashemi; S J Banihashemi
Journal:  Indian J Nephrol       Date:  2012-01

10.  The role of aldosterone blockade in murine lupus nephritis.

Authors:  Seetha U Monrad; Paul D Killen; Marc R Anderson; Amanda Bradke; Mariana J Kaplan
Journal:  Arthritis Res Ther       Date:  2008-01-15       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.